Enzyme-Driven Peptide Hydrogel Coatings with Hyaluronic Acid Could Improve Implant Compatibility

Peptide hydrogels were grown on surfaces using localized enzyme-assisted self-assembly with varying concentrations of hyaluronic acid (2, 5, and 10 mg/mL). The coatings were characterized using electron microscopy, fluorescent confocal microscopy, and rheological measurements. Cell viability and adhesion were tested using NIH 3T3 fibroblast cultures.

Medical implants often trigger inflammation because the body recognizes them as foreign. Coating implants with biocompatible hydrogels could reduce this reaction. This study demonstrates a fully biocompatible method to create tunable peptide coatings that incorporate hyaluronic acid — a molecule the body already produces — which could lead to implants that integrate more smoothly with surrounding tissue.

Surface coatings for biomedical implants are a major research focus as devices like joint replacements, stents, and dental implants become more common. Peptide-based hydrogels offer an advantage over synthetic polymers because they can be designed to mimic natural tissue. This work adds a new dimension by showing that hyaluronic acid — already FDA-approved in other applications — can be incorporated to fine-tune coating properties.

This is an in vitro study only. The coatings have not been tested on actual implants in animal models or humans. Only one cell type (fibroblasts) was evaluated, so performance with other relevant cell types (immune cells, osteoblasts) is unknown. Long-term stability and degradation behavior in physiological conditions were not assessed.